Online voting is available for pharmacists in District 4 (central Alberta).
All stimulants and gabapentinoids are now monitored as Type 2 TPP medications.
New versions of the agreements are available on the ACP website.
Two new members will join the committee after being elected by their Council peers.
Health Canada has developed a single webpage directory of their controlled substance resources.
Increasing rates of resistance and adverse drug reactions should limit use.
Virtual care will impact pharmacy teams across the province – now is your chance to shape the future.
Compounding must occur pursuant to a prescription and not for stock management purposes.
Lessons Learned: health information must only be accessed for authorized purposes.
Lessons Learned: licensees are responsible for the supervision and conduct of unregulated pharmacy employees.
Loss or theft reports can no longer be submitted via fax.
A survey is now available to provide your feedback.
Clarifying legislated requirements regarding roles and supervision in the pharmacy.
Key points for pharmacy teams from ACP’s updated standards of practice.
Registrants are encouraged to review the draft standards and provide feedback by May 24, 2022.
The nomination deadline is fast approaching!
All pharmacies can now order Paxlovid.
Pharmacies will begin to receive their ACP-provided materials in the coming weeks.
Virtual care will be the topic for our first in-person meetings in over two years.
Pharmacists are required to confirm refill intervals for part-filled prescriptions.
